WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005107871) PYRROLOQUINOLINE QUINONE DRUGS FOR TREATMENT OF CARDIAC INJURY
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/107871    International Application No.:    PCT/US2005/015742
Publication Date: 17.11.2005 International Filing Date: 05.05.2005
IPC:
A61P 9/10 (2006.01), A61K 31/475 (2006.01), A61K 31/135 (2006.01)
Applicants: CLF MEDICAL TECHNOLOGY ACCELERATION PROGRAM, INC. [US/US]; 747 Pierce Road, Clifton Park, NY 12065 (US) (For All Designated States Except US).
DAVIS, Paul, J. [US/US]; (US) (For US Only).
KARLINER, Joel, S. [US/US]; (US) (For US Only)
Inventors: DAVIS, Paul, J.; (US).
KARLINER, Joel, S.; (US)
Agent: ELRIFI, Ivor, R.; Mintz, Levin, Cohn, Gerris, Glovsky and Popeo PC, One Financial Center, Boston, MA 02111 (US)
Priority Data:
60/568,353 05.05.2004 US
60/617,508 08.10.2004 US
Title (EN) PYRROLOQUINOLINE QUINONE DRUGS FOR TREATMENT OF CARDIAC INJURY
(FR) MEDICAMENTS A BASE DE PYRROLOQUINOLINE QUINONE DESTINES AU TRAITEMENT DE LESIONS CARDIAQUES ET PROCEDES D'UTILISATION CORRESPONDANTS
Abstract: front page image
(EN)The invention includes compositions comprising purified pyrrologuinoline guinone drugs, that are useful in methods for the treatment and prevention of cardiac injury caused by hypoxia or ischemia. The invention also includes methods for the treatment and prevention of cardiac injury comprising contacting a composition of the invention with a human patient.
(FR)L'invention concerne des compositions comprenant un pyrroloquinoline quinone sensiblement purifié, utilisées dans des procédés de traitement et de prévention des lésions cardiaques provoquées par l'hypoxie ou l'ischémie. L'invention concerne également des procédés destinés au traitement ou à la prévention de lésions cardiaques, qui consiste à administrer la composition de l'invention à un patient humain.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)